All News

President Obama’s move to focus on “science as economic saviour” may have stalled. But there is still optimism about the impact the new administration will have.

The pipeline of drugs in development in French biotechs saw a significant increase in 2008, but the funding climate may undermine this advance, says France Biotech.

Cambridge spin-out CamSemi hopes to prosper during the global economic storm by riding the green wave. Its trump card: a new way of converting mains current to DC.

The Steinbeis-Transfer-Institute for Intellectual Property Management has developed a set of indicators of the commercial viability of collaborative life-science projects.